U.S. Cases Increase 4.4%; Gilead Drug Gets FDA Nod: Virus Update
Funeral directors move a cremation box into a room at a funeral home in the Queens borough of New York, U.S. (Photographer: Angus Mordant/Bloomberg)

U.S. Cases Increase 4.4%; Gilead Drug Gets FDA Nod: Virus Update

(Bloomberg) -- Gilead Sciences Inc.’s antiviral drug remdesivir was cleared by U.S. regulators for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.